Company intelligence / Profile preview

Cell Microsystems

Durham, North Carolina, United Statescellmicrosystems.com ↗

Ownership: Private
Development stage: Commercial

Overview

Cell Microsystems develops and commercializes innovative platforms and contract research services that enable high-efficiency imaging, sorting, isolation, and analysis of single cells and colonies. Their proprietary technologies are widely used in CRISPR gene editing workflows, stem cell biology, organoid development, oncology research, immunology studies, and neurobiology. The company's tools have demonstrated significant improvements in clonal outgrowth efficiency from challenging cell types compared to traditional methods.

Modalities: Device3D cell culture systemAutomated cell analysis platform
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Cell Microsystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell Microsystems.

Explore the full profile